iBio Inc

Company Snapshot
8800 HSC Parkway
Bryan, TX 77807-1107
United States
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 23
https://www.ibioinc.com
Please select from the dropdown
Company Financials

2021
2022
2023
Gross Profit
$909,000
$2,167,000
Operating Income
($31,111,000)
($49,690,000)
($29,343,000)
Net Income
($23,207,000)
($50,303,000)
($65,010,000)
2021
Gross Profit
$909,000
Operating Income
($31,111,000)
Net Income
($23,207,000)
2022
Gross Profit
$2,167,000
Operating Income
($49,690,000)
Net Income
($50,303,000)
2023
Gross Profit
Operating Income
($29,343,000)
Net Income
($65,010,000)
The above data on iBio Inc came from annual proxy statements to the SEC. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov
Top Executives
Total Cash info
Equity info
Other info
Total Compensation
Top Executives
Total Compensation
Thomas Isett
President, Chief Executive Officer and Chairman of the Board
$1,040,000
$2,012,464
$16,250
$3,068,714
Thomas Isett
$3,068,714
President, Chief Executive Officer and Chairman of the Board
Martin Brenner
Chief Scientific Officer
$567,000
$757,887
$11,302
$1,336,189
Martin Brenner
$1,336,189
Chief Scientific Officer
Robert Lutz
Chief Financial Officer and Principal Accounting Officer
$595,000
$541,348
$21,574
$1,157,922
Robert Lutz
$1,157,922
Chief Financial Officer and Principal Accounting Officer
William Clark
Director
$50,008
$173,573
$0
$223,581
William Clark
$223,581
Director
James Hill
Independent Director
$62,658
$65,304
$0
$127,962
James Hill
$127,962
Independent Director
iBio Inc listed the above executives on its annual proxy statement to the SEC for the fiscal year of 2022. You may retrieve the full proxy statement by going to the Securities and Exchange Commission (SEC) website at www.sec.gov

The sum of all cash payments made to an individual for services during a given year. It is comprised of yearly Base Pay and Bonuses

To view more detailed proxy data including previous years contact our sales team.

Contact Us

The value of stock and option awards plus long term incentives granted.

To view more detailed proxy data including previous years contact our sales team.

Contact Us

This covers all compensation that don't fit in any of these other standard categories

To view more detailed proxy data including previous years contact our sales team.

Contact Us